Archives for July 2008

July 2008 - Page 5 of 12 - Money Morning - Only the News You Can Profit From

Global Investing Roundups

Icahn's Yahoo Victory; XM Gains Listeners; Gloomy Economic Outlook; Crude Gains on Tropical/Political Storms; Hasbro Beats Expectations; Corn Cut Down; Goldman Banker Summoned by Paulson; Union Asks Citi to Break Up Operations Yahoo! Inc. (YHOO) agreed to give three spots on its board of directors to activist investor Carl Icahn, a vocal opponent of the […]

Read More…

Fishing for Profits in the Fannie/Freddie Flotsam

By Martin HutchinsonContributing Editor The bailout of mortgage giants Fannie Mae (FNM) and Freddie Mac (FRE) is extremely confusing to holders of their debt and equity securities, because it's very difficult to figure out what the final outcome of the “rescue" might be, and if so, who benefits. However, as a service to Money Morning […]

Read More…

Consumer Spending Threatened by High Prices and Lower Wages

By Jason SimpkinsAssociate Editor Consumer spending, which accounts for more than 70% of the economy, will be seriously threatened in the months ahead, as prices continue to rise, wages plateau, and government stimulus checks wear thin. Consumer spending has remained strong in recent months, even jumping 0.8% in the month of May. But that boost […]

Read More…

Bank of America, Citigroup Spark Glimmer of Hope for Troubled U.S. Banking Industry

By Jennifer YousfiManaging Editor Bank of America Corp. (BAC) shares soared yesterday (Monday) as it followed Citigroup Inc.’s (C) lead to become the fourth large domestic bank to beat Wall Street’s earnings expectations and provide hope that the battered banking industry might finally be leaving the worst of the subprime mess behind. Bank of America […]

Read More…

Switzerland’s Roche Makes $43.7 Billion Offer for U.S. Biotech Pioneer Genentech

By Jennifer YousfiManaging Editor Roche Holding Ltd. (OTC ADR: RHHBY) yesterday (Monday) announced a $43.7 billion offer for the 44% of Genentech Inc. (DNA) it doesn't already own. Switzerland-based Roche’s $89 per share cash offer is almost a 9% premium over San Francisco-based Genentech’s Friday closing price. Roche first acquired 60% of Genentech for $2.1 […]

Read More…

New Bull Market or Bear-Market Trap? Investors Look to Earnings Season for Clues

By William Patalon IIIExecutive EditorMoney Morning/The Money Map Report Earnings season will plug along this week as reports from several banks provide the latest insight into how well the beleaguered financial-services sector is weathering the global credit-crisis storm. Among the earnings season headlines: Bank of America Corp. (BAC) will be issuing its final earnings report […]

Read More…

Buy, Sell or Hold: Chevron Corp.

Chevron Corp. (CVX), the second-largest U.S. oil company, has recently experienced a decimation of its share price: The stock has dropped nearly 20% from its 52-week high of nearly $105 to Friday's close of $86.05. But here's the thing: At some point down here, Chevron's stock becomes quite a compelling buy. Let me explain. The […]

Read More…

Oil's Double-Digit Slide Shouts "Sell!" to Some

By Jennifer YousfiManaging Editor Oil's recent wild ride has some market experts questioning which way black gold is headed in the weeks, months, and even years ahead. Oil dropped over 11% during a volatile week of trading, as reduced consumer demand put downward pressure on the once hot commodity. Crude oil for August delivery ended […]

Read More…